Literature DB >> 2998592

Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus.

V Giancotti, M T Berlingieri, P P DiFiore, A Fusco, G Vecchio, C Crane-Robinson.   

Abstract

Two-dimensional electrophoresis has been used to document changes in nuclear proteins following viral transformation of an epithelial cell line exhibiting differentiation markers. After transformation, these markers are lost, and the cells become tumorigenic and capable of growth in soft agar. A sharp rise in the phosphorylation of histones H1, H2A, and ubiquitinated H2A is seen on transformation, together with the appearance of three phosphorylated proteins that are extractable by perchloric acid and appear related to high mobility group Protein 14, a constituent of active chromatin. Since comparison is made between normal and transformed cells that are each grown to confluence and since there is little difference between their observed growth rates, the changes seen represent intrinsic differences between the cell lines and are thus a direct reflection of the process of transformation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998592

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes.

Authors:  G Manfioletti; V Giancotti; A Bandiera; E Buratti; P Sautière; P Cary; C Crane-Robinson; B Coles; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

3.  The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element.

Authors:  K Y Chau; U A Patel; K L Lee; H Y Lam; C Crane-Robinson
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

4.  NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C.

Authors:  F Mantovani; S Covaceuszach; A Rustighi; R Sgarra; C Heath; G H Goodwin; G Manfioletti
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

Review 5.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

6.  Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.

Authors:  G Tallini; P Dal Cin; K J Rhoden; G Chiapetta; G Manfioletti; V Giancotti; A Fusco; H Van den Berghe; R Sciot
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

7.  Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.

Authors:  M T Berlingieri; G Manfioletti; M Santoro; A Bandiera; R Visconti; V Giancotti; A Fusco
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

8.  Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins.

Authors:  V Giancotti; A Bandiera; C Sindici; L Perissin; C Crane-Robinson
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 9.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

10.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.